Member Info for You_Having_a_Laugh

It looks like this should already be 2x where it is. Why isn't it? Either there is a big step up due or I've missed something. I already hold from earlier in the summer. The CEO has been a regular buyer at higher prices. Why hasn't it moved at all? I don't believe they can be happy with this but I can't see anything in the public domain to reverse the situation or get more exposure.

What would be a realistic value now? I could see it being twice where it is simply on the basis of looking at what it would cost to set up the products + the existing level of business. The company seems quite happy with the share price as it is else they would be pushing out mooe news. If they are happy - why?

The margin is likely to be very volume sensitive. At high volume they couold probably shell them out at say 50p each. Guesswork. Does siver get used in the process?

Why can't London South East read both sets of trades and sum them up? I've noticed Barclays trades arrive on Plus more often than they used to a while back, may be a cheaper platform, so without both sets the numbers are deceiving. I don't remember ever seeing one of my holding flat-line in such a way as Mediwatch. Not so much as a sign of a pulse.

Yes - about that time but I didn't see it. Thanks again. Looks like it but I must have missed it Friday.

Friday, 100K at about 2.63p. Trade went though in seconds but didn't show for the day.

If a share trade was made (a buy) is there any reason at all why it wouldn't show that day especially if the buy was during the morning? Is there a legal requirement for a trade to be shown? The trade in question would not have been on Plus. Thanks.

Given how tight lending criteria have become the sooner the company has a cash cushion of their own the better. Might it be the RNS was worded to keep "the masses" off the scent until the directors have had a chance to buy after any closed period?

Expect another buy-out approach.